Ground Swell Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ground Swell Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1K	Buy	+167	New	+$1.8K	﹤0.01%	2255

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ground Swell Capital's GNMK Position: Q3 2014 in Review

Ground Swell Capital opened a new position in GenMark Diagnostics, Inc (GNMK) in Q3 2014: 167 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2255 among its holdings.

82 funds tracked by Wall St. Rank hold GNMK as of Q3 2014.

Ground Swell Capital held 167 shares of GenMark Diagnostics, Inc worth $1K as of Q3 2014.
GenMark Diagnostics, Inc was a new Ground Swell Capital position in Q3 2014.
GenMark Diagnostics, Inc made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2255 holding.
82 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.